E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Modern diabetic foot care includes structured neurological and vascular evaluation, angiosome-based assessment and evidence-based wound management approaches that support early intervention and help reduce the risk of serious complications.
imphoenix82
Amygdala Neurosciences is initially developing ANS-858 as a potential treatment for alcohol use disorder and other substance use disorders.
imphoenix82
Patients and Industry experts are calling for full insurance coverage of prosthetic and orthotic services to help more amputees lead independent lives and contribute to the country’s economy.
dineshwori
Under the new agreement, Henlius will grant Sandoz exclusive rights to register and commercialize up to 10 partnered products outside China
imphoenix82
With the unit classified as VAI, Aurobindo Pharma said pending applications for multiple inhalers and other dosage forms filed from the facility can now progress through the USFDA’s review process.
imphoenix82
Redcliffe Labs and Skyroot Aerospace’s first mission, DRIFT-1, will test dry diagnostic reagents in low Earth orbit for 90 days.
imphoenix82
Lilly is calling on regulators, customs agencies, law enforcement authorities, online platforms, and payment companies to shut down the illegal retatrutide black market.
imphoenix82
Deepak Sapra currently serves as the chief executive officer – API and Services at Dr. Reddy’s Laboratories and as a board member of Aurigene Pharma Services. He will join Gland Pharma effective November 16, 2026.
imphoenix82
Aurobindo Pharma said the warning letter to Unit I of Eugia Pharma Specialities will have no impact on existing supplies to the US market.
imphoenix82
Motorica India and Tehlin plan to introduce advanced lower-limb prostheses at prices around 35-40% lower than those of major European players such as Ottobock, with scope for further price reductions as volumes increase.
dineshworiHealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
